N-Acetyltransferase Phenotype of Patients with Bladder Cancer
Karakaya, A.E.; Cok, I.; Sardas, S.; Gögüs, O.; Sardas, O.S.; Karakaya, A.E., Department of Toxicology, Gazi University, Faculty of Pharmacy; Cok, I., Department of Toxicology, Gazi University, Faculty of Pharmacy; Sardas, S., Department of Toxicology, Gazi University, Faculty of Pharmacy; Gögüs, O., Department of Urology, Ankara University, Faculty of Medicine, Ankara, Turkey; Sardas, O.S., Department of Hematology and Oncology3, Ankara University, Faculty of Medicine, Ankara, Turkey
Журнал:
Human and Experimental Toxicology
Дата:
1986
Аннотация:
1 N-Acetyltransferase phenotype has been determined in 109 control subjects and in 23 patients with bladder cancer.2 Sixty-two per cent of control, and 39% of patients with bladder cancer were phenotypically slow acetylators. This difference was not significant.3 N-Acetyltransferase phenotype is unlikely to be a major determinant in the development of bladder cancer in the Turkish population.
215.3Кб